ABCC8 p.Ala90Val
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 17635943
[PubMed]
Suzuki S et al: "Molecular basis of neonatal diabetes in Japanese patients."
No.
Sentence
Comment
7
Five mutations were novel: two (p.A174G and p.C166Y) in KCNJ11, two (p.A90V and p.N1122D) in ABCC8, and one (p.P367L) in FOXP3.
X
ABCC8 p.Ala90Val 17635943:7:71
status: NEW56 The novel mutations were the substitution of alanine by valine at codon 90 (c.269CϾT, p.A90V) and the substitution of asparagine by aspartate at codon 1122 (c.3364AϾG, p.N1122D).
X
ABCC8 p.Ala90Val 17635943:56:45
status: NEWX
ABCC8 p.Ala90Val 17635943:56:94
status: NEW79 They exhibited hyperglycemia, leading to fever and dehydration in the patient with the A90V mutation and severe DKA, resulting in seizure in the patient with the N1122D mutation.
X
ABCC8 p.Ala90Val 17635943:79:89
status: NEW88 The patients with R50G, C166Y, R201C, or R201H in the KCNJ11 and A90V mutations or N1122D in the ABCC8 mutation have been treated with insulin since diagnosis of diabetes.
X
ABCC8 p.Ala90Val 17635943:88:65
status: NEW98 Sex Year of birth Age at last visit (yr) Diabetes form Genetic defect Age at onset of diabetes (d) Age at remission (d) Remark 1 M 2001 0.7 TNDM pUPD(6) 10 161 Macroglossia at onset 2 M 2002 2.8 TNDM pUPD(6) 9 104 Macroglossia at onset 3 M 2005 0.6 TNDM pUPD(6) 4 62 4 F 2002 0.3 TNDM pUPD(6) 11 62 Macroglossia at onset 5 F 2003 2.0 TNDM pUPD(6) 0 91 Extremely premature baby 6 F 2005 0.4 TNDM pUPD(6) 8 39 7 F 2000 5.4 TNDM pUPD(6) 1 26 Prominent forehead 8 M 2004 0.7 TNDM 6q24 duplication 6 16 9 M 2002 2.5 TNDM 6q24 duplication 2 173 Macroglossia at onset 10 M 2004 0.9 TNDM 6q24 duplication 8 35 Macroglossia at onset 11 F 1994 11.2 TNDM 6q24 duplication 6 246 Recurrence at 10 yr of age (38) 12 M 2003 1.3 TNDM KCNJ11 (p.R50Q) 9 307 13 M 1986 14.6 TNDM KCNJ11 (p.A174G) 17 307 Recurrence at 13 yr of age 14 M 2004 2.0 PNDM KCNJ11 (p.R201H) 33 15 F 2004 0.5 PNDMa KCNJ11 (p.R201H) 54 16 M 2004 2.0 PNDM KCNJ11 (p.R201H) 42 17 M 2006 0.3 PNDMa KCNJ11 (p.R201H) 54 18 F 2000 5.0 PNDM KCNJ11 (p.R201C) 49 19 M 1997 8.3 PNDM KCNJ11 (p.R50G) 115 DEND syndrome, arthroglyposis 20 F 2003 3.1 PNDM KCNJ11 (p.C166Y) 98 DEND syndrome, arthroglyposis, prominent forehead, ptosis 21 M 2004 1.7 PNDM ABCC8 (p.A90V) 40 22 M 2006 0.3 PNDMa ABCC8 (p.N1122D) 50 23 M 2001 0.3 PNDM FOXP3 (p.P367 liter) 8 Died at 4 months of age 24 M 2000 3.6 TNDM Unknown 10 27 Extremely premature baby 25 M 2001 0.2 TNDM Unknown 11 25 Extremely premature baby 26 M 2005 0.2 TNDM Unknown 13 60 Macroglossia at onset 27 M 2003 1.9 PNDM Unknown (no IPF1 mutation) 9 Pancreatic agenesis 28 M 2002 3.4 PNDM Unknownb 42 29 M 2002 1.2 PNDM Unknown 18 Congenital deafness, cataract, mental retardation, liver dysfunction 30 M 1991 13.9 PNDM Unknown 55 Severe developmental delay 31 F 2002 3.0 PNDM Unknown 93 Congenital cataract, severe developmental delay F, Female; M, male.
X
ABCC8 p.Ala90Val 17635943:98:1202
status: NEW159 The novel A90V and N1122D mutations are located in TMD0 and TMD2, respectively.
X
ABCC8 p.Ala90Val 17635943:159:10
status: NEW162 Thus, the functional consequence of the novel mutations A90V and N1122D is likely to overactivate beta-cell ATP-sensitive Kϩ channels.
X
ABCC8 p.Ala90Val 17635943:162:56
status: NEW
PMID: 20922570
[PubMed]
Edghill EL et al: "Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11."
No.
Sentence
Comment
85
One of the most notable R1183W/Q A1185E E1327K G1401R V1523A/L V1524M R1531A NBD1 NBD2 outside membrane inside P45L N72S F132L/V L135P P207S E208K D209E Q211K D212I/N L213R L225P T229I Y263D A269D/N E382K V86A/G R1380C/H/L C435R L438F M1290V L451P R826W R1314H TMD0 TMD1 TMD2 R306H V324M L582V H1024Y I1425V A90V Y356C R521Q N1123D R1153G T1043TfsX74 Fig. 3 Schematic representation of 50 ABCC8 mutations which cause neonatal diabetes.
X
ABCC8 p.Ala90Val 20922570:85:308
status: NEW
PMID: 18990670
[PubMed]
Aittoniemi J et al: "Review. SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator."
No.
Sentence
Comment
204
(a) (b) P45L N72S F132L NH2 A90V V86G COOHL135P exoplasmic cytoplasmic Walker A Walker A linker Walker B linker Walker B V324M E382K C435R L438F L582V R826W H1023Y N1122D R1183Q A1185E R1314H E1327K R1380 L I1425V V1524 L P207S E208K Q211K D212I/N L225P T229I Y263D A269D R306H D209E L213R TMD0 TMD1 TMD2 NBD1 NBD2 CL3 linker site 1 site 2 NBD1 NBD2 R826W R1380 L E1327K I1425V V1524 L Figure 5.
X
ABCC8 p.Ala90Val 18990670:204:28
status: NEW207 (a) (b) P45L N72S F132L NH2 A90V V86G COOH L135P exoplasmic cytoplasmic Walker A Walker A linker Walker B linker Walker B V324M E382K C435R L438F L582V R826W H1023Y N1122D R1183Q A1185E R1314H E1327K R1380 L I1425V V1524 L P207S E208K Q211K D212I/N L225P T229I Y263D A269D R306H D209E L213R TMD0 TMD1 TMD2 NBD1 NBD2 CL3 linker site 1 site 2 NBD1 NBD2 R826W R1380 L E1327K I1425V V1524 L Figure 5.
X
ABCC8 p.Ala90Val 18990670:207:28
status: NEW